State Key Lab of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing 100021, PR China.
Mol Oncol. 2013 Oct;7(5):955-67. doi: 10.1016/j.molonc.2013.05.005. Epub 2013 Jun 13.
Small proline-rich repeat protein 3 (SPRR3) has been linked with the altered chemoradiosensitivity, however the underlying molecular mechanisms remain elusive. Here, we report that ectopic overexpression of SPRR3 enhanced the sensitivity of cells in response to DNA damage-induced apoptosis via loss of mitochondrial membrane potential (MMP), and increasing activation of caspase 3 in human esophageal cancer cell lines. Conversely, siRNA knockdown of SPRR3 reduced apoptosis. We found that SPRR3 was localized in mitochondria and interacted with Bcl-2 in vivo, thus facilitating Bax mitochondrial translocation and the subsequent release of cytochrome c, and thereby enhancing cell sensitivity to DNA damage stimuli. In clinical samples, expression of SPRR3 was associated with the pathologic response (P = 0.007 in radiotherapy group, P = 0.035 in preoperative radiotherapy group) and good survival of patients with locally advanced esophageal squamous cell carcinoma (ESCC, P = 0.008). Taken together, our results implicate that SPRR3 might serve as a radiation-sensitive predictor of ESCC.
富含脯氨酸的小蛋白 3(SPRR3)与改变的放化疗敏感性有关,但其潜在的分子机制尚不清楚。在这里,我们报告了 SPRR3 的异位过表达通过丧失线粒体膜电位(MMP)增强了细胞对 DNA 损伤诱导的细胞凋亡的敏感性,并增加了人食管癌细胞系中 caspase 3 的激活。相反,SPRR3 的 siRNA 敲低减少了细胞凋亡。我们发现 SPRR3 在线粒体中定位,并与体内的 Bcl-2 相互作用,从而促进 Bax 线粒体易位和随后的细胞色素 c 的释放,从而增强细胞对 DNA 损伤刺激的敏感性。在临床样本中,SPRR3 的表达与病理反应(放疗组 P=0.007,术前放疗组 P=0.035)和局部晚期食管鳞状细胞癌(ESCC)患者的良好生存相关(P=0.008)。综上所述,我们的结果表明 SPRR3 可能是 ESCC 的辐射敏感预测因子。